AJANTA PHARMA LTD.

Company Profile

AJANTA PHARMA LTD. had its IPO on under the ticker symbol AJANTPHARM.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. AJANTA PHARMA LTD. has a staff strength of 7,713 employees.

Stock update

Shares of AJANTA PHARMA LTD. opened at ₹1739.95 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹1700.15 - ₹1753.55, and closed at ₹1716.5.

This is a -0.85% slip from the previous day's closing price.

A total volume of 3,956 shares were traded at the close of the day’s session.

In the last one week, shares of AJANTA PHARMA LTD. have slipped by -0.17%.

AJANTA PHARMA LTD.'s Key Ratios

AJANTA PHARMA LTD. has a market cap of ₹222.24 billion, indicating a price to book ratio of 4.3686 and a price to sales ratio of 4.4707.

In the last 12-months AJANTA PHARMA LTD.’s revenue was ₹38.13 billion with a gross profit of ₹26.92 billion and an EBITDA of ₹8.34 billion. The EBITDA ratio measures AJANTA PHARMA LTD.'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, AJANTA PHARMA LTD.’s operating margin was 18.82% while its return on assets stood at 9.47% with a return of equity of 17.68%.

In Q2, AJANTA PHARMA LTD.’s quarterly earnings growth was a positive 21.3% while revenue growth was a positive 7.4%.

AJANTA PHARMA LTD.’s PE and PEG Ratio

Forward PE

0

Trailing PE

38.4364

PEG

Its diluted EPS in the last 12-months stands at ₹45.92 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into AJANTA PHARMA LTD.’s profitability.

AJANTA PHARMA LTD. stock is trading at a EV to sales ratio of 4.28 and a EV to EBITDA ratio of 15.2905. Its price to sales ratio in the trailing 12-months stood at 4.4707.

AJANTA PHARMA LTD. stock pays annual dividends of ₹7 per share, indicating a yield of 0.56% and a payout ratio of 34.84%.

Balance sheet and cash flow metrics

Total Assets

₹46.79 billion

Total Liabilities

₹11.39 billion

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

34.84%

AJANTA PHARMA LTD. ended 2025 with ₹46.79 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹46.79 billion while shareholder equity stood at ₹33.88 billion.

AJANTA PHARMA LTD. ended 2025 with ₹0 in deferred long-term liabilities, ₹11.39 billion in other current liabilities, 252700000.00 in common stock, ₹33.63 billion in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹3.30 billion and cash and short-term investments were ₹8.44 billion. The company’s total short-term debt was ₹0 while long-term debt stood at ₹12.50 million.

AJANTA PHARMA LTD.’s total current assets stands at ₹28.25 billion while long-term investments were ₹0 and short-term investments were ₹5.13 billion. Its net receivables were ₹10.57 billion compared to accounts payable of ₹4.23 billion and inventory worth ₹8.16 billion.

In 2025, AJANTA PHARMA LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, AJANTA PHARMA LTD. paid ₹0.35 in dividends in 2025.

Other key metrics

Current Trading Price

₹1716.5

52-Week High

₹1804.7

52-Week Low

₹1102.4797

Analyst Target Price

₹

AJANTA PHARMA LTD. stock is currently trading at ₹1716.5 per share. It touched a 52-week high of ₹1804.7 and a 52-week low of ₹1804.7. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹1619.96 and 200-day moving average was ₹1341.22 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 6644.4% of the company’s stock are held by insiders while 2240.8% are held by institutions.